The findings from a single-patient gene therapy trial at The Hospital for Sick Children (SickKids) show promise in halting the progression of a young Toronto boy’s rare disease. Michael Pirovolakis has spastic paraplegia type 50 (SPG50), an “ultra-rare” neurodegenerative disorder that causes developmental delays, speech impairment, seizures and progressive paralysis. …
Read More »
Asian Tribune Your Multilingual Newspaper covering World and local news News